Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Lee HJ et al. | 2012 | intact cell/cell culture, NIH3T3 cells (mouse fibroblasts), normal and transfected with a c-Myc-containing vector or with an empty vetor | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
Lee HM et al. | 2010 | intact cell/cell culture, human intervertebral disc cells | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 1.8 mT |
Lee YJ et al. | 2016 | intact cell/cell culture, CD4<sup>+</sup> T cells derived from mice (C57/BL6 mice and Foxp3-GFP mice) | magnetic field, 50/60 Hz | 0.3 mT |
Lekovic MH et al. | 2020 | intact cell/cell culture, MRC-5 (human diploid fibroblasts) | 50/60 Hz, magnetic field | 10 mT |
Leone L et al. | 2014 | intact cell/cell culture, neural stem cells from newborn mice, animal, mouse/C57bl/6, whole body | magnetic field, 50/60 Hz | 1 mT |
Li X et al. | 2012 | intact cell/cell culture, mesenchymal bone marrow stem cells (from femurae and tibiae of Sprague-Dawley rats) | magnetic field, signals/pulses, 50/60 Hz | 10 mT |
Li X et al. | 2019 | animal, mouse/C57BL/6 | magnetic field, 50/60 Hz | 5 mT |
Li Y et al. | 2014 | intact cell/cell culture, culture medium, K562 and HEL 92.1.7 cells (human erythroleukemic cell lines), MCF-7 cells (human breast cancer cell line), NCI-H460 cells (human lung cancer cell line), Colo 320 DM cells (human colon carcinoma cell line) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 4 nT–74 µT |
Liburdy RP et al. | 1993 | intact cell/cell culture, MCF-7 cells (melatonin-sensitive breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 0.19–1.195 µT |
Liu C et al. | 2013 | intact cell/cell culture, rat bone marrow mesenchymal stromal cells | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.